These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 24114184)

  • 1. The cross-talk between estrogen receptor and peroxisome proliferator-activated receptor gamma in thyroid cancer.
    Chu R; van Hasselt A; Vlantis AC; Ng EK; Liu SY; Fan MD; Ng SK; Chan AB; Liu Z; Li XY; Chen GG
    Cancer; 2014 Jan; 120(1):142-53. PubMed ID: 24114184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Effects of Estrogen Receptor Alpha and Beta on Endogenous Ligands of Peroxisome Proliferator-Activated Receptor Gamma in Papillary Thyroid Cancer.
    Yang S; Gong Z; Liu Z; Wei M; Xue L; Vlantis AC; Zhang Y; Chan JY; van Hasselt CA; Zeng X; Qiu S; Tang N; Du J; Wei W; Tong MC; Chen GG
    Front Endocrinol (Lausanne); 2021; 12():708248. PubMed ID: 34557159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of peroxisome proliferator-activated receptor γ inhibits estrogen receptor α transcriptional activity in endometrial carcinoma cells.
    Zhang G; Hou X; Gao S
    Oncol Rep; 2015 Mar; 33(3):1227-34. PubMed ID: 25592200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis Induced by the UV Filter Benzophenone-3 in Mouse Neuronal Cells Is Mediated via Attenuation of Erα/Pparγ and Stimulation of Erβ/Gpr30 Signaling.
    Wnuk A; Rzemieniec J; Lasoń W; Krzeptowski W; Kajta M
    Mol Neurobiol; 2018 Mar; 55(3):2362-2383. PubMed ID: 28357806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chaperone-mediated Autophagy Governs Progression of Papillary Thyroid Carcinoma via PPARγ-SDF1/CXCR4 Signaling.
    Zhou H; Xie X; Chen Y; Lin Y; Cai Z; Ding L; Wu Y; Peng Y; Tang S; Xu H
    J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32556197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of estrogen receptors with E2 downregulates peroxisome proliferator-activated receptor γ in hepatocellular carcinoma.
    Lin YM; Velmurugan BK; Yeh YL; Tu CC; Ho TJ; Lai TY; Tsai CH; Tsai FJ; Tsai CH; Huang CY
    Oncol Rep; 2013 Dec; 30(6):3027-31. PubMed ID: 24126791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dibutyl Phthalate (DBP)-Induced Apoptosis and Neurotoxicity are Mediated via the Aryl Hydrocarbon Receptor (AhR) but not by Estrogen Receptor Alpha (ERα), Estrogen Receptor Beta (ERβ), or Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) in Mouse Cortical Neurons.
    Wójtowicz AK; Szychowski KA; Wnuk A; Kajta M
    Neurotox Res; 2017 Jan; 31(1):77-89. PubMed ID: 27581038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
    Lin MS; Chen WC; Bai X; Wang YD
    J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression patterns and clinical significance of estrogen receptor-α and β in papillary thyroid carcinoma.
    Huang Y; Dong W; Li J; Zhang H; Shan Z; Teng W
    BMC Cancer; 2014 May; 14():383. PubMed ID: 24884830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor gamma inhibits follicular and anaplastic thyroid carcinoma cells growth by upregulating p21Cip1/WAF1 gene in a Sp1-dependent manner.
    Bonofiglio D; Qi H; Gabriele S; Catalano S; Aquila S; Belmonte M; Andò S
    Endocr Relat Cancer; 2008 Jun; 15(2):545-57. PubMed ID: 18509005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisomal proliferator-activated receptor-gamma agonists induce partial reversion of epithelial-mesenchymal transition in anaplastic thyroid cancer cells.
    Aiello A; Pandini G; Frasca F; Conte E; Murabito A; Sacco A; Genua M; Vigneri R; Belfiore A
    Endocrinology; 2006 Sep; 147(9):4463-75. PubMed ID: 16777971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells.
    Cotrim CZ; Fabris V; Doria ML; Lindberg K; Gustafsson JÅ; Amado F; Lanari C; Helguero LA
    Oncogene; 2013 May; 32(19):2390-402. PubMed ID: 22751110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptor alpha binds to peroxisome proliferator-activated receptor response element and negatively interferes with peroxisome proliferator-activated receptor gamma signaling in breast cancer cells.
    Bonofiglio D; Gabriele S; Aquila S; Catalano S; Gentile M; Middea E; Giordano F; Andò S
    Clin Cancer Res; 2005 Sep; 11(17):6139-47. PubMed ID: 16144913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G Protein-coupled Receptor 40 (GPR40) and Peroxisome Proliferator-activated Receptor γ (PPARγ): AN INTEGRATED TWO-RECEPTOR SIGNALING PATHWAY.
    Wang S; Awad KS; Elinoff JM; Dougherty EJ; Ferreyra GA; Wang JY; Cai R; Sun J; Ptasinska A; Danner RL
    J Biol Chem; 2015 Aug; 290(32):19544-57. PubMed ID: 26105050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal cross-talk between estrogen receptor alpha and beta and the peroxisome proliferator-activated receptor gamma1 in MDA-MB-231 and MCF-7 breast cancer cells.
    Wang X; Kilgore MW
    Mol Cell Endocrinol; 2002 Aug; 194(1-2):123-33. PubMed ID: 12242035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contributions of oestrogen receptor isoforms to the development of papillary and anaplastic thyroid carcinomas.
    Zeng Q; Chen G; Vlantis A; Tse G; van Hasselt C
    J Pathol; 2008 Mar; 214(4):425-33. PubMed ID: 18085520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor effects of peroxisome proliferator activate receptor gamma ligands on anaplastic thyroid carcinoma.
    Hayashi N; Nakamori S; Hiraoka N; Tsujie M; Xundi X; Takano T; Amino N; Sakon M; Monden M
    Int J Oncol; 2004 Jan; 24(1):89-95. PubMed ID: 14654945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of peroxisome proliferator-activated receptor-γ (PPARγ) inhibits hepatoma cell growth via downregulation of SEPT2 expression.
    Cao LQ; Shao ZL; Liang HH; Zhang DW; Yang XW; Jiang XF; Xue P
    Cancer Lett; 2015 Apr; 359(1):127-35. PubMed ID: 25592041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic actions of estrogen receptor beta (ERbeta) are mediated by a negative cross-talk with PPARgamma.
    Foryst-Ludwig A; Clemenz M; Hohmann S; Hartge M; Sprang C; Frost N; Krikov M; Bhanot S; Barros R; Morani A; Gustafsson JA; Unger T; Kintscher U
    PLoS Genet; 2008 Jun; 4(6):e1000108. PubMed ID: 18584035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oestrogen mediates the growth of human thyroid carcinoma cells via an oestrogen receptor-ERK pathway.
    Zeng Q; Chen GG; Vlantis AC; van Hasselt CA
    Cell Prolif; 2007 Dec; 40(6):921-35. PubMed ID: 18021179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.